相关实验视频

Updated: Jun 22, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

素酸作为胆癌的潜在治疗剂

Jiabao Liang¹, Tong Wen¹, Xiaojian Zhang²

¹Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning 530021, China.

Pharmaceuticals (Basel, Switzerland)

|June 27, 2024

概括

酸 (CGA) 通过抑制细胞生长和促进细胞亡,对胆管癌 (CCA) 产生强大的抗瘤作用. CGA针对AKR1B10,抑制瘤进展并增强抗瘤免疫力.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

酸 (CGA) 在各种癌症中表现出抗瘤特性.
在胆管癌 (CCA) 中CGA的治疗潜力尚未得到充分证实.

研究的目的:

调查CGA在胆管癌 (CCA) 中的抗瘤作用和潜在机制.

主要方法:

进行了细胞增殖,迁移,入侵和亡测试.
分析了表皮层-介质细胞过渡 (EMT) 和细胞周期进展.
评估了与阿尔多-基托减少酶1B10 (AKR1B10) 和其下游信号 (AKT) 的结合亲和力.
评估了与瘤相关的巨细胞 (TAM) 两极化和T细胞细胞毒性.

主要成果:

CGA显著抑制了CCA细胞的增殖,迁移,殖民地形成和入侵,同时抑制了EMT.
CGA诱导的亡和调节的细胞循环进展.
CGA表现出对AKR1B10的结合亲和力,减少其表达,随后抑制AKT激活.
AKR1B10淘汰赛抑制了增殖,而过度表达促进了增殖;即使在AKR1B10过度表达的情况下,CGA也抑制了增殖.
CGA促进了抗瘤TAM极化,并增强了T细胞细胞毒性.

结论:

酸 (CGA) 通过多种机制对胆管癌 (CCA) 具有显著的抗瘤活性.
CGA的治疗潜力包括准AKR1B10/AKT信号和调节瘤免疫微环境.
CGA代表了CCA治疗开发的有希望的候选人.

关键词:

在 AKR1B1010 中,灭症 (apoptosis) 是一种死亡的过程.原酸是一种原酸.胆瘤是一种胆瘤.巨细胞的两极分化瘤免疫的微环境

更多相关视频

Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining

Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining

Published on: March 17, 2023

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

相关概念视频

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Endoscopic Procedures V: ERCP

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...